Why Pediatrix Medical Group, Inc.’s (MD) Stock Is Up 5.39%
As of Friday, August 22, Pediatrix Medical Group, Inc.’s MD share price has surged by 5.39%, which has investors questioning if this is right time to sell.Jenna Brashear
Stock Evaluator: Pediatrix Medical Group, Inc. (MD)
Pediatrix Medical Group, Inc. MD
$26.51
0.03
0.11%
July 31, 2026 4:00:02 PM
EST
Volume: 453,556
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Commentary & Analysis
Why Pediatrix Medical Group, Inc.’s (MD) Stock Is Up 5.43%
As of Wednesday, August 13, Pediatrix Medical Group, Inc.’s MD share price has surged by 5.43%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Pediatrix Medical Group, Inc.’s (MD) Stock Is Up 6.89%
As of Wednesday, August 06, Pediatrix Medical Group, Inc.’s MD share price has surged by 6.89%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Pediatrix Medical Group, Inc.’s (MD) Stock Is Up 11.46%
As of Tuesday, August 05, Pediatrix Medical Group, Inc.’s MD share price has surged by 11.46%, which has investors questioning if this is right time to sell.Jenna Brashear
3 Undervalued Health Care Providers & Services Stocks for Tuesday, July 29
Discover the top 3 undervalued Health Care Providers & Services stocks for Tuesday, July 29 based on AAII’s Stock Grades.Tudor Pop
Financial Summary
| Share Statistics | MD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,125.8 | $1,742.7 | 55% |
|
| Shares Out (Mil) | 83.1 | 76.7 | 59% |
|
| Institutional Ownership | 98.5% | 89.7% | 80% |
|
| Float (Mil) | 78.8 | 49.4 | 57% |
|
| Beta | 0.70 | 0.82 | 41% |
|
| Avg Daily Volume (000s) | 594 | 521 | 62% |
|
| Price Change (52-week) |
113.8% | 78.7% | 93% |
|
| Growth | MD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.0% | 11.0% | 23% |
|
| Net Income (5yr) | 17.2% | (0.7%) | 68% |
|
| EPS (5yr) | 17.1% | 3.1% | 62 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (32.3%) | (18.0%) | 17% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 6 | |
| Current EPS | $0.591 | $2.276 | $2.360 | |
| Month Ago EPS | $0.591 | $2.276 | $2.360 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $0.592 | $2.234 | $2.326 | |
| Year/Year Chg | 64.2% | 17.3% | 18.1% | |
| Financials | MD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,932 | $1,456 | 60% |
|
| Net Income (TTM) (Mil) | $174 | $12 | 67% |
|
| EPS (TTM) | $2.094 | $0.300 | 72% |
|
| Operating Cash Flow (TTM) (Mil) | $259 | $138 | 62% |
|
| Net Cash Flow (TTM) (Mil) | $107 | $8 | 78% |
|
| Long-Term Debt (Q1) (Mil) | $425 | $316 | 57% |
|
| Enterprise Value (Q1) (Mil) | $2,237 | $2,170 | 51% |
|
| Valuation | MD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.42 | 2.85 | 58% |
|
| P/E | 12.8 | 26.7 | 27% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.2 | 1.1 | 5% |
|
| Ratios | MD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 26.1% | 27.8% | 29% |
|
| Net Margin | 9.0% | 1.1% | 60% |
|
| ROA | 8.6% | 1.8% | 85% |
|
| ROE | 20.9% | 7.1% | 81% |
|
| Liabilities to Assets | 57.6% | 59.9% | 51% |
|
| F-Score | 8 | 5 | 94% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
O'Shaughnessy: Growth Screen II
Factors: Value, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 15.1% |
| +/- S&P 500: | +7.6 |
